Supreme Court lifts mail ban on abortion pill mifepristone

Supreme Court lifts mail ban on abortion pill mifepristone

In this photo illustration, A packet of Mifepristone is seen at Wyoming’s last abortion clinic, Wellspring Center March 10, 2025 in Casper, Wyoming.

Natalie Behring | Getty Images

The U.S. Supreme Court on Monday temporarily lifted a lower court’s ban on the abortion pill mifepristone being sent through the mail.

The administrative stay of the ban on mailing of mifepristone issued Friday by the 5th U.S. Circuit Court of Appeals will continue until at least 5 p.m. ET May 11, but could be extended after that.

Supreme Court Justice Samuel Alito, who granted the temporary pause, gave the state of Louisiana until 5 p.m. Thursday to respond to requests that the 5th Circuit’s ruling be blocked as litigation over the issue plays out.

Read more CNBC politics coverage

Two drugmakers, Danco Laboratories and GenBioPro, over the weekend asked the Supreme Court to lift the ban on mifepristone being distributed through the mail.

The drug is used in about two-thirds of all abortions in the United States.

Louisiana had sued the Food and Drug Administration over its 2023 decision to lift a rule that mifepristone had to be administered in person.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *